218 related articles for article (PubMed ID: 7655019)
1. Expression of bcl-xL can confer a multidrug resistance phenotype.
Minn AJ; Rudin CM; Boise LH; Thompson CB
Blood; 1995 Sep; 86(5):1903-10. PubMed ID: 7655019
[TBL] [Abstract][Full Text] [Related]
2. Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis.
Dole MG; Jasty R; Cooper MJ; Thompson CB; Nuñez G; Castle VP
Cancer Res; 1995 Jun; 55(12):2576-82. PubMed ID: 7780971
[TBL] [Abstract][Full Text] [Related]
3. Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells.
Huang Y; Ibrado AM; Reed JC; Bullock G; Ray S; Tang C; Bhalla K
Leukemia; 1997 Feb; 11(2):253-7. PubMed ID: 9009089
[TBL] [Abstract][Full Text] [Related]
4. Bcl-2 and Bcl-XL can differentially block chemotherapy-induced cell death.
Simonian PL; Grillot DA; Nuñez G
Blood; 1997 Aug; 90(3):1208-16. PubMed ID: 9242554
[TBL] [Abstract][Full Text] [Related]
5. Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression.
Kern MA; Helmbach H; Artuc M; Karmann D; Jurgovsky K; Schadendorf D
Anticancer Res; 1997; 17(6D):4359-70. PubMed ID: 9494534
[TBL] [Abstract][Full Text] [Related]
6. Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines.
Nuessler V; Stötzer O; Gullis E; Pelka-Fleischer R; Pogrebniak A; Gieseler F; Wilmanns W
Leukemia; 1999 Nov; 13(11):1864-72. PubMed ID: 10557064
[TBL] [Abstract][Full Text] [Related]
7. Bcl-2, Bcl-XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death.
Huang DC; Cory S; Strasser A
Oncogene; 1997 Jan; 14(4):405-14. PubMed ID: 9053837
[TBL] [Abstract][Full Text] [Related]
8. Alteration of the Bcl-2/Bax status of head and neck cancer cell lines by chemotherapeutic agents.
Kawakami K; Tsukuda M; Mizuno H; Nishimura G; Ishii A; Hamajima K
Anticancer Res; 1999; 19(5B):3927-32. PubMed ID: 10628333
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells.
Walczak H; Bouchon A; Stahl H; Krammer PH
Cancer Res; 2000 Jun; 60(11):3051-7. PubMed ID: 10850456
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of apoptosis-related bcl-2 but not bcl-xL or bax proteins in multidrug-resistant MCF-7/Adr human breast cancer cells.
Ogretmen B; Safa AR
Int J Cancer; 1996 Sep; 67(5):608-14. PubMed ID: 8782646
[TBL] [Abstract][Full Text] [Related]
11. Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents.
Decaudin D; Geley S; Hirsch T; Castedo M; Marchetti P; Macho A; Kofler R; Kroemer G
Cancer Res; 1997 Jan; 57(1):62-7. PubMed ID: 8988042
[TBL] [Abstract][Full Text] [Related]
12. Expression of Bcl-xL and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage.
Minn AJ; Boise LH; Thompson CB
Genes Dev; 1996 Oct; 10(20):2621-31. PubMed ID: 8895663
[TBL] [Abstract][Full Text] [Related]
13. Bax can antagonize Bcl-XL during etoposide and cisplatin-induced cell death independently of its heterodimerization with Bcl-XL.
Simonian PL; Grillot DA; Merino R; Nuñez G
J Biol Chem; 1996 Sep; 271(37):22764-72. PubMed ID: 8798452
[TBL] [Abstract][Full Text] [Related]
14. BAX enhances paclitaxel-induced apoptosis through a p53-independent pathway.
Strobel T; Swanson L; Korsmeyer S; Cannistra SA
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14094-9. PubMed ID: 8943066
[TBL] [Abstract][Full Text] [Related]
15. Distinct apoptotic responses imparted by c-myc and max.
Nesbit CE; Fan S; Zhang H; Prochownik EV
Blood; 1998 Aug; 92(3):1003-10. PubMed ID: 9680370
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance modulators PSC 833 and CsA show differential capacity to induce apoptosis in lymphoid leukemia cell lines independently of their MDR phenotype.
Lopes EC; Garcia M; Benavides F; Shen J; Conti CJ; Alvarez E; Hajos SE
Leuk Res; 2003 May; 27(5):413-23. PubMed ID: 12620293
[TBL] [Abstract][Full Text] [Related]
17. Bcl-xL inhibits different apoptotic pathways in rat PC12 cells.
Lindenboim L; Haviv R; Stein R
Neurosci Lett; 1998 Aug; 253(1):37-40. PubMed ID: 9754799
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Bcl-XS sensitizes MCF-7 cells to chemotherapy-induced apoptosis.
Sumantran VN; Ealovega MW; Nuñez G; Clarke MF; Wicha MS
Cancer Res; 1995 Jun; 55(12):2507-10. PubMed ID: 7780958
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel.
Wang Z; Goulet R; Stanton KJ; Sadaria M; Nakshatri H
Anticancer Res; 2005; 25(3c):2367-79. PubMed ID: 16080463
[TBL] [Abstract][Full Text] [Related]
20. Overcoming of multidrug resistance by introducing the apoptosis gene, bcl-Xs, into MRP-overexpressing drug resistant cells.
Ohi Y; Kim R; Toge T
Int J Oncol; 2000 May; 16(5):959-69. PubMed ID: 10762632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
